APA (7th ed.) Citation

X, H., G, P., Y, K., X, C., & X, Z. (2025). The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors. Journal of Inflammation Research, 18, 203-217.

Chicago Style (17th ed.) Citation

X, Huang, Peng G, Kong Y, Cao X, and Zhou X. "The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors." Journal of Inflammation Research 18 (2025): 203-217.

MLA (9th ed.) Citation

X, Huang, et al. "The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors." Journal of Inflammation Research, vol. 18, 2025, pp. 203-217.